These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9647615

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
    von Pawel J, von Roemeling R, Gatzemeier U, Boyer M, Elisson LO, Clark P, Talbot D, Rey A, Butler TW, Hirsh V, Olver I, Bergman B, Ayoub J, Richardson G, Dunlop D, Arcenas A, Vescio R, Viallet J, Treat J.
    J Clin Oncol; 2000 Mar; 18(6):1351-9. PubMed ID: 10715308
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.
    Treat J, Johnson E, Langer C, Belani C, Haynes B, Greenberg R, Rodriquez R, Drobins P, Miller W, Meehan L, McKeon A, Devin J, von Roemeling R, Viallet J.
    J Clin Oncol; 1998 Nov; 16(11):3524-7. PubMed ID: 9817270
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
    Li JL, Zhang XR, Liu JW, Chen ZY, Lin YC, Wang YD, Chen Q, Nan KJ, Song SP, Han FC, Zhu YZ, Li LY, Zheng YH, Chu DT.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
    [Abstract] [Full Text] [Related]

  • 10. Tirapazamine: from bench to clinical trials.
    Marcu L, Olver I.
    Curr Clin Pharmacol; 2006 Jan; 1(1):71-9. PubMed ID: 18666379
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypoxic sensitizer and cytotoxin for head and neck cancer.
    Lee DJ, Moini M, Giuliano J, Westra WH.
    Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
    [Abstract] [Full Text] [Related]

  • 13. High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer.
    Schiller JH.
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):78-82. PubMed ID: 8783672
    [Abstract] [Full Text] [Related]

  • 14. Is there a role for tirapazamine in the treatment of cervical cancer?
    Ghatage P, Sabagh H.
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1589-97. PubMed ID: 23033890
    [Abstract] [Full Text] [Related]

  • 15. Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
    Devore R, Johnson D, Crawford J, Dimery I, Eckardt J, Eckhardt SG.
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):79-83. PubMed ID: 9726097
    [Abstract] [Full Text] [Related]

  • 16. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.
    Williamson SK, Crowley JJ, Lara PN, McCoy J, Lau DH, Tucker RW, Mills GM, Gandara DR, Southwest Oncology Group Trial S0003.
    J Clin Oncol; 2005 Dec 20; 23(36):9097-104. PubMed ID: 16361616
    [Abstract] [Full Text] [Related]

  • 17. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S, Bier A, Thierbach U, Virchow C, Ketterer P, Fietkau R.
    Strahlenther Onkol; 2003 Dec 20; 179(12):823-31. PubMed ID: 14652671
    [Abstract] [Full Text] [Related]

  • 18. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
    Covens A, Blessing J, Bender D, Mannel R, Morgan M, Gynecologic Oncology Group.
    Gynecol Oncol; 2006 Mar 20; 100(3):586-90. PubMed ID: 16249022
    [Abstract] [Full Text] [Related]

  • 19. Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
    Senan S, Rampling R, Graham MA, Wilson P, Robin H, Eckardt N, Lawson N, McDonald A, von Roemeling R, Workman P, Kaye SB.
    Clin Cancer Res; 1997 Jan 20; 3(1):31-8. PubMed ID: 9815534
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.
    Aghajanian C, Brown C, O'flaherty C, Fleischauer A, Curtin J, Roemeling R, Spriggs DR.
    Gynecol Oncol; 1997 Nov 20; 67(2):127-30. PubMed ID: 9367694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.